ProKidney shareholders approve reincorporation from Cayman Islands to Delaware

PROKIDNEY CORP.

Domestication approved with 227.6M for, 1.1M against; expected completion by end of Q3 2025.
New Delaware charter adopted; authorized shares set at 700M Class A, 500M Class B, 50M preferred.
Directors Culleton, Legorreta, Sinha elected to three-year terms (avg ~226M for each).
Ernst & Young ratified as independent auditor for fiscal year 2025 (238.6M for).
Advisory charter proposals approved, including exclusive forum, written consent removal, supermajority vote requirements.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.